Paper36964252
Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification.
Jung S and 7 others. Exp Mol Med, 2023. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification. Papers, record 36964252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964252
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Encephalomyelitis, Autoimmune, Experimental | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Extracellular Vesicles | Major topic |
| Animals | |
| Mice | |
| Nuclear Receptor Subfamily 1, Group F, Member 3 | |
| Th17 Cells | |
| Cell Differentiation | |
| Protein Processing, Post-Translational |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 37100897 | Author Correction: Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing RORγt through posttranslational modification. | https://conductscience.org/library/papers/37100897 |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32784057 | Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4+ T cell. | Life Sci | 2020 | https://conductscience.org/library/papers/32784057 | PubMed |
| 2 | 32733020 | IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32733020 | PubMed |
| 3 | 16557264 | Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16557264 | PubMed |
| 4 | 21103959 | Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α (CD25) cleavage by producing matrix metalloproteinases. | Stem Cell Rev Rep | 2011 | https://conductscience.org/library/papers/21103959 | PubMed |
| 5 | 30526632 | A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD. | J Hematol Oncol | 2018 | https://conductscience.org/library/papers/30526632 | PubMed |
| 6 | 32111238 | Mesenchymal stem cells regulate the Th17/Treg cell balance partly through hepatocyte growth factor in vitro. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/32111238 | PubMed |
| 7 | 23056000 | Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. | Front Immunol | 2012 | https://conductscience.org/library/papers/23056000 | PubMed |
| 8 | 21871655 | Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. | Cell | 2011 | https://conductscience.org/library/papers/21871655 | PubMed |
| 9 | 21339713 | Isolation of brain and spinal cord mononuclear cells using percoll gradients. | J Vis Exp | 2011 | https://conductscience.org/library/papers/21339713 | PubMed |
| 10 | 30992990 | Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. | Biomark Res | 2019 | https://conductscience.org/library/papers/30992990 | PubMed |
| 11 | 27481185 | Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases. | Cytokine Growth Factor Rev | 2016 | https://conductscience.org/library/papers/27481185 | PubMed |
| 12 | 11559745 | p300/CBP proteins: HATs for transcriptional bridges and scaffolds. | J Cell Sci | 2001 | https://conductscience.org/library/papers/11559745 | PubMed |
| 13 | 24745332 | Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. | Immunity | 2014 | https://conductscience.org/library/papers/24745332 | PubMed |
| 14 | 24903975 | Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. | Hum Cell | 2014 | https://conductscience.org/library/papers/24903975 | PubMed |
| 15 | 21151032 | Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21151032 | PubMed |
| 16 | 31023504 | Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. | Eur J Cell Biol | 2019 | https://conductscience.org/library/papers/31023504 | PubMed |
| 17 | 29239062 | Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations. | Stem Cells | 2018 | https://conductscience.org/library/papers/29239062 | PubMed |
| 18 | 16880778 | Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16880778 | PubMed |
| 19 | 32460853 | Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/32460853 | PubMed |
| 20 | 15987788 | EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15987788 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903835 | Extracellular vesicle-mediated immune remodeling in cutaneous wound repair. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903835 | PubMed |
| 42883805 | Regulatory T Cells Across Oral Diseases: A Narrative Review on a Functional Perspective. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883805 | PubMed |
| 42647266 | Advancing Sports Injury Treatment Through Cell-Free MSC-Based Therapies: A Narrative Review. | Muscles | 2026 | https://conductscience.org/library/papers/42647266 | PubMed |
| 42598067 | Extracellular vesicle-mediated immune crosstalk in rheumatoid arthritis synovium: mechanistic insights and translational challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42598067 | PubMed |
| 42523644 | Systemic regulation of rheumatoid arthritis by mesenchymal stem cells: from immune homeostasis to microbiota modulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42523644 | PubMed |
| 42256888 | The mechano-immune-vesicle regulatory circuit: a systems framework for bone homeostasis and regeneration. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42256888 | PubMed |
| 41484803 | Mesenchymal stem cell-derived extracellular vesicles in musculoskeletal regeneration: mechanisms, applications, and future prospects. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41484803 | PubMed |
| 41350499 | Platelet-rich fibrin-derived extracellular vesicles: emerging biological mediators in periodontal regeneration. | Odontology | 2026 | https://conductscience.org/library/papers/41350499 | PubMed |
| 40717077 | Mesenchymal stem cell-derived extracellular vesicles attenuate periductal fibrosis by inhibiting Th17 differentiation in human liver multilineage organoids and Mdr2-/- mice. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40717077 | PubMed |
| 40698145 | Antisense oligonucleotides targeting IRF4 alleviate psoriasis. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40698145 | PubMed |
| 40341605 | Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial. | Sci Rep | 2025 | https://conductscience.org/library/papers/40341605 | PubMed |
| 40234973 | Harnessing exosomes for targeted drug delivery systems to combat brain cancer. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40234973 | PubMed |
| 40205436 | Zinc finger DHHC-type palmitoyltransferase 13-mediated S-palmitoylation of GNA13 from Sertoli cell-derived extracellular vesicles inhibits autophagy in spermatogonial stem cells. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40205436 | PubMed |
| 40181198 | Extracellular vesicles: translational research and applications in neurology. | Nat Rev Neurol | 2025 | https://conductscience.org/library/papers/40181198 | PubMed |
| 39821702 | Mesenchymal stem cell-derived extracellular vesicles in periodontal bone repair. | J Mol Med (Berl) | 2025 | https://conductscience.org/library/papers/39821702 | PubMed |
| 39758422 | Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4+T cells in immune diseases. | Biophys Rep | 2024 | https://conductscience.org/library/papers/39758422 | PubMed |
| 39483335 | Mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis: role and therapeutic directions. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39483335 | PubMed |
| 39377219 | USP26 Combats Age-Related Declines in Self-Renewal and Multipotent Differentiation of BMSC by Maintaining Mitochondrial Homeostasis. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39377219 | PubMed |
| 39372581 | Emerging Role and Mechanism of Mesenchymal Stem Cells-Derived Extracellular Vesicles in Rheumatic Disease. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39372581 | PubMed |
| 39264247 | The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering. | Immun Inflamm Dis | 2024 | https://conductscience.org/library/papers/39264247 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| EID3 | 493861 | PubTator's text mining | https://conductscience.org/library/genes/493861 | NCBI Gene |
| EP300 | 2033 | PubTator's text mining | https://conductscience.org/library/genes/2033 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| RORC | 6097 | PubTator's text mining | https://conductscience.org/library/genes/6097 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36964252
GET https://conductscience.org/api/papers/v1/36964252/references?page=2